Solid Oral Formulation Of Fenretinide
Patent No. EP3171860 (titled "Solid Oral Formulation Of Fenretinide") was filed by Laurent Pharmaceuticals on Jul 24, 2015. The application was issued on Dec 11, 2024.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3171860
- Application Number
- EP15825528A
- Filing Date
- Jul 24, 2015
- Status
- Granted And Under Opposition
- Nov 8, 2024
- Publication Date
- Dec 11, 2024
- External Links
- Slate, Register , Google Patents